New study reveals the extent of antibiotic misuse for a common... - 18 November 2022 11:01

LONDON, November, 18, 2022, /PRNewswire-AsiaNet/-- A new global study launched during World Antimicrobial Awareness Week (WAAW, 18-24 November) shows a high dependence on antibiotics for treating respiratory conditions like sore throat, which is helping to fuel antibiotic resistance - the third le...

  MED-EL Presents: ideas4ears and calls for child inventors to a... - 18 November 2022 09:00

INNSBRUCK, Austria, Nov. 17, 2022 /PRNewswire-AsiaNet/ -- Global children's contest launched on World Inventors Day to raise awareness of hearing loss and the benefits of treatment Photo - https://mma.prnewswire.com/media/1946442/Aim_high_for_science.jpg Logo - https://mma.prnewswire.com/media/18602...

  In operation the most innovative 11.74T MRI Core Magnet to be ... - 17 November 2022 19:25

GENOA, Italy, Nov. 17, 2022 /PRNewswire-AsiaNet/ -- The world's first simultaneous multi-channel/multi-nuclear 11.74T MRI system is currently under development at Gachon University Gil Medical Center (GUGMC). In the first Half of 2022 GUGMC successfully completed the Site Acceptance Test of the ...

  An end to smoking is within reach - it must not be allowed to ... - 16 November 2022 01:17

LONDON, Nov. 15, 2022 /PRNewswire-AsiaNet/-- In a landmark new Global State of Tobacco Harm Reduction (GSTHR) report, experts are calling on global policymakers to seize the opportunity to bring about an end to smoking, which every year kills eight million people worldwide. Despite years of ...

  Alphyn Biologics Completes First Cohort of Phase2a Clinical Tr... - 15 November 2022 23:30

ANNAPOLIS, Md., Nov. 15, 2022 /PRNewswire-AsiaNet/ -- Alphyn Biologics ( https://c212.net/c/link/?t=0&l=en&o=3709054-1&h=2795132862&u=https%3A%2F%2Falphynbiologics.com%2F&a=Alphyn+Biologics ), a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced today th...

  LumiraDx Continues Commercial Expansion of its Rapid Microflui... - 15 November 2022 03:14

LONDON, November 14, 2021 /PRNewswire-AsiaNet/-- - Now Available in Europe, parts of the Middle East, Asia, Latin America, and Africa - Early customers include GP offices and other community-based healthcare settings - Latest figures, released as part of World Diabetes Day, reveal that 1 ...

  RedHill Accelerates Opaganib's Nuclear Radiation Protection Pr... - 15 November 2022 00:44

TEL AVIV, Israel and RALEIGH, NC, November 14, 2022 /PRNewswire-AsiaNet/ -- Strong preclinical data, recently published in the International Journal of Molecular Sciences, from eight U.S government-funded in-vivo opaganib studies, supports opaganib's potential as a nuclear radiation injury therapeutic for homeland securit...

  SENTINEL DIAGNOSTICS LAUNCHES SENTINAT(R) 200, THE FULLY AUTOM... - 14 November 2022 20:00

MILAN, November, 14, 2022, /PRNewswire-AsiaNet/-- Sentinel CH. SpA today announced the launch of SENTiNAT(R) 200, the fully automated sample to result system, and SENT-NAT(R) SN200 Real-Time PCR assays for the quantitative detection of 10 viruses. SENTiNAT(R) 200 and STAT-NAT(R) SN200 kits repres...

  TauRx Announces Additional Investment of USD119 million follow... - 14 November 2022 18:00

ABERDEEN, Scotland and SINGAPORE, Nov. 14, 2022 /PRNewswire-AsiaNet/ -- - Substantial investment of USD119 million achieved by TauRx through a warrants exercise triggered by the announcement of LUCIDITY results in October, supporting HMTM regulatory submissions in UK, US and Canada, and preparation for market availabi...

  LOTUS REPORTS ITS BEST QUARTER EVER WITH THE BIGGEST LAUNCH IN... - 11 November 2022 21:00

TAIPEI, Taiwan, Nov. 11, 2022 /PRNewswire-AsiaNet/ -- Lotus Pharmaceutical (1795: TT), a multinational pharmaceutical company, today reported its financial results for the third quarter ended 30 September 2022. Third quarter financial highlights: - Third quarter 2022 is the best quarter ever in...